Medtronic plc (MDT) Financials
Annual revenue, profitability and per-share results for Medtronic plc, as reported in SEC filings.
Revenue • FY2026
$36.36B
▲ 8.4%YoY
Net income • FY2026
$4.8B
▲ 3.0%YoY
Gross margin • FY2026
65.0%
Diluted EPS • FY2026
$3.73
▲ 3.3%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2026 | $36.36B | $4.8B | $23.64B | $3.73 | $5.43B | 17.8% | +8.4% |
| FY2025 | $33.54B | $4.66B | $21.91B | $3.61 | $5.18B | 17.8% | +3.6% |
| FY2024 | $32.36B | $3.68B | $21.15B | $2.76 | $5.2B | 15.9% | +3.6% |
| FY2023 | $31.23B | $3.76B | $20.51B | $2.82 | $4.58B | 17.6% | -1.5% |
Figures as reported in Medtronic plc's 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Never miss a MDT filing.
Get an email when MDT files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.